DRUGS AND SUPPLEMENTS

Sweet annie (Artemisia annua)

March 22, 2017

../../images/ss_sweetannie.jpg

Sweet annie (Artemisia annua)

Natural Standard Bottom Line Monograph, Copyright © 2013 (www.naturalstandard.com). Commercial distribution prohibited. This monograph is intended for informational purposes only, and should not be interpreted as specific medical advice. You should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

While some complementary and alternative techniques have been studied scientifically, high-quality data regarding safety, effectiveness, and mechanism of action are limited or controversial for most therapies. Whenever possible, it is recommended that practitioners be licensed by a recognized professional organization that adheres to clearly published standards. In addition, before starting a new technique or engaging a practitioner, it is recommended that patients speak with their primary healthcare provider(s). Potential benefits, risks (including financial costs), and alternatives should be carefully considered. The below monograph is designed to provide historical background and an overview of clinically-oriented research, and neither advocates for or against the use of a particular therapy.

Related Terms

  • Artemether, Artemisia annua, Artemisia annua essential oil, Artemisia apiacea, artemisia ketone, Artemisia lancea, arteannuin-B, arteether, artemether, artemetin, artemisinic acid, artemisinin, artemotil, artenimol, artesunate, artimesinin, beta-caryophyllene, beta-selinene, camphor, Chinese wormwood, deoxyartemisinin, dihydroartemisinin, dihydroqinghaosu, endoperoxide sesquiterpene lactone artemisinin, friedelin, germacrene D, oriental wormwood, qing hao (Chinese), qing hao su (Chinese), qinghaosu (Chinese), quinghao (Chinese), sodium artesunate, stigmasterol, sweet wormwood, thanh hao (Vietnamese), trans-pinocarveol, yin-chen.

  • Note: This monograph does not include information on wormwood (absinthe, Artemisia absinthium) or mugwort (Artemisia vulgaris).

Background

  • Sweet annie (Artemisia annua) is also known as Chinese wormwood or sweet wormwood. Although it is in the same genus as both wormwood (absinthe, Artemisia absinthium) and mugwort (Artemisia vulgaris), each of these herbs has different uses and should not be confused.

  • For more than 1,500 years, sweet annie tea was used in traditional Chinese medicine (TCM) to treat fevers, although the herb fell out of favor for a few centuries. In 1970, a TCM handbook from the 5th Century was discovered and stimulated interest in sweet annie. Although originally used to treat fevers, sweet annie was not used specifically for malaria.

  • Sweet annie's main active constituent is artemisinin, which has shown rapid antimalarial activity in humans, especially when used as an adjuvant with standard antimalarial drugs. Considered a weed by some, the plant can be grown in many climates and a simple and effective preparation of Artemisia annua could be a much-needed inexpensive and convenient weapon against malaria. In addition to its promise in treating malaria, preliminary evidence indicates that sweet annie may have potential as an anticancer agent and an antiviral.

Scientific Evidence

Uses

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Grade*

Cancer

Certain constituents found in sweet annie show promise when used in combination with standard chemotherapy. However, currently there is not enough scientific evidence in humans to make a strong recommendation for this use.

C

Malaria

Malaria is a serious health concern in many poorer parts of the world where modern antimalarial drugs may not be available. Although there has been some interest in using sweet annie as an antimalarial, there is currently not enough human evidence to make a strong recommendation.

C

*Key to grades:A: Strong scientific evidence for this use; B: Good scientific evidence for this use; C: Unclear scientific evidence for this use; D: Fair scientific evidence against this use (it may not work); F: Strong scientific evidence against this use (it likely does not work).

Tradition/Theory

The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious and should be evaluated by a qualified health care professional.

  • Antibacterial, antioxidant, antiparasitic, antiviral, fever, immunosuppression, leukemia, melanoma, neonatal jaundice

Dosing

The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.

Adults (over 18 years old)

  • There is no proven safe or effective dose for sweet annie in adults.

Children (under 18 years old)

  • There is no proven safe or effective dose for sweet annie in children.

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Allergies

  • Avoid in individuals with a known allergy or hypersensitivity to sweet annie or members of the Asteraceae/Compositae family such as dandelion, goldenrod, ragweed, sunflower, and daisy.

Side Effects and Warnings

  • Certain constituents in sweet annie (artemisinin and artesunate) have been well-tolerated when taken by mouth with no reported adverse effects. However, there is a lack of available information on the safety of sweet annie and caution is advised.

  • Use cautiously in patients with compromised heart or brain function, as a related species has shown potential toxicity.

  • Use cautiously in patients who are pregnant or recovering from surgery or other wounds.

  • Use cautiously in patients with compromised immune function, as sweet annie may have immunosuppressive activity.

Pregnancy and Breastfeeding

  • Sweet annie is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence. Sweet annie may inhibit angiogenesis, which is the development of new blood vessels.

Interactions

Most herbs and supplements have not been thoroughly tested for interactions with other herbs, supplements, drugs, or foods. The interactions listed below are based on reports in scientific publications, laboratory experiments, or traditional use. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy.

Interactions with Drugs

  • Sweet annie may inhibit angiogenesis, which is the development of new blood vessels. Caution is advised in patients taking agents that affect angiogenesis.

  • Although not well studied in humans, sweet annie may also inhibit bacterial and fungal growth. Thus, patients taking antibiotics and antifungals should be aware that additive effects might occur.

  • Artesunate, a constituent found in sweet annie, may be incompatible with quinolines, which are used as food preservatives and in making antiseptics. These should not be confused with quinolones, which are a family of broad-spectrum antibiotics.

  • Sweet annie has been studied for its antimalarial and anticancer effects and use with other antimalarial or anticancer agents may have additive effects.

  • Sweet annie may have antioxidant and immunosuppressive activity. Consult with a qualified healthcare professional, including a pharmacist, to check for possible interactions.

Interactions with Herbs and Dietary Supplements

  • Sweet annie may inhibit angiogenesis, which is the development of new blood vessels. Caution is advised in patients taking herbs or supplements that affect angiogenesis.

  • Although not well studied in humans, sweet annie may also inhibit bacterial and fungal growth. Thus, patients taking antibiotics and antifungals should be aware that additive effects might occur.

  • Sweet annie has been studied for its antimalarial and anticancer effects and use with other antimalarial or anticancer herbs or supplements may have additive effects.

  • Sweet annie may have antioxidant and immunosuppressive activity. Consult with a qualified healthcare professional, including a pharmacist, to check for possible interactions with herbs or supplements with these effects.

Author Information

  • This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).

References

Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.

  1. Berger TG, Dieckmann D, Efferth T, et al. Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep. 2005;14(6):1599-1603. View Abstract

  2. Bertea CM, Freije JR, van der Woude H, et al. Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Med 2005;71(1):40-47. View Abstract

  3. Chen HH, Zhou HJ, Wu GD, et al. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 2004;71(1):1-9. View Abstract

  4. Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets. 2006;7(4):407-421. View Abstract

  5. Haynes RK. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem 2006;6(5):509-537. View Abstract

  6. Heide L. Artemisinin in traditional tea preparations of Artemisia annua. Trans R.Soc Trop.Med Hyg 2006;100(8):802. View Abstract

  7. Hsu E. The history of qing hao in the Chinese materia medica. Trans R.Soc Trop.Med Hyg 2006;100(6):505-508. View Abstract

  8. Lommen WJ, Schenk E, Bouwmeester HJ, et al. Trichome dynamics and artemisinin accumulation during development and senescence of Artemisia annua leaves. Planta Med 2006;72(4):336-345. View Abstract

  9. Mueller MS, Runyambo N, Wagner I, et al. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans.R.Soc.Trop.Med Hyg. 2004;98(5):318-321. View Abstract

  10. Rath K, Taxis K, Walz G, et al. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop.Med Hyg. 2004;70(2):128-132. View Abstract

  11. Romero MR, Serrano MA, Vallejo M, et al. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med 2006;72(13):1169-1174. View Abstract

  12. Singh NP, Lai HC. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res 2005;25(6B):4325-4331. View Abstract

  13. Van der Meersch H. [Review of the use of artemisinin and its derivatives in the treatment of malaria]. J Pharm Belg. 2005;60(1):23-29. View Abstract

  14. Wu GD, Zhou HJ, Wu XH. Apoptosis of human umbilical vein endothelial cells induced by artesunate. Vascul.Pharmacol. 2004;41(6):205-212. View Abstract

  15. Yance DR Jr., Sagar SM. Targeting angiogenesis with integrative cancer therapies. Integr.Cancer Ther. 2006;5(1):9-29. View Abstract

Copyright © 2013 Natural Standard (www.naturalstandard.com)

The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.

Updated:  

March 22, 2017